Li Jinling, Xu Weitong, Liang Yibiao, Wang Hui
School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
Research Department of Pharmacognosy, China Pharmaceutical University, Nanjing, Jiangsu, China.
Pharmacol Rep. 2017 Apr;69(2):252-259. doi: 10.1016/j.pharep.2016.10.011. Epub 2016 Oct 13.
Metabolomics is a powerful emerging tool for the identification of biomarkers and the exploration of metabolic pathways in a high-throughput manner. As an administration site for percutaneous absorption, the skin has a variety of metabolic enzymes, except other than hepar. However, technologies to fully detect dermal metabolites remain lacking. Skin metabolomics studies have mainly focused on the regulation of dermal metabolites by drugs or on the metabolism of drugs themselves. Skin metabolomics techniques include collection and preparation of skin samples, data collection, data processing and analysis. Furthermore, studying dermal metabolic effects via metabolomics can provide novel explanations for the pathogenesis of some dermatoses and unique insights for designing targeted prodrugs, promoting drug absorption and controlling drug concentration. This paper reviews current progress in the field of skin metabolomics, with a specific focus on dermal drug delivery systems and dermatosis.
代谢组学是一种强大的新兴工具,可用于高通量鉴定生物标志物和探索代谢途径。作为经皮吸收的给药部位,皮肤除了肝素外还有多种代谢酶。然而,仍缺乏全面检测皮肤代谢物的技术。皮肤代谢组学研究主要集中在药物对皮肤代谢物的调节或药物本身的代谢上。皮肤代谢组学技术包括皮肤样本的采集与制备、数据收集、数据处理与分析。此外,通过代谢组学研究皮肤代谢效应可为某些皮肤病的发病机制提供新的解释,并为设计靶向前药、促进药物吸收和控制药物浓度提供独特见解。本文综述了皮肤代谢组学领域的当前进展,特别关注皮肤给药系统和皮肤病。